Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria
Clinical trial NCT00097955 · COMPLETED
Trial details
- NCT number
- NCT00097955
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2007-04-01
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.